News

Pfizer Recalls Five Lots of Accupril

April 22, 2022

Read More »

Zerbaxa Now Indicated for Children

April 21, 2022

Read More »

Single Batch of Lantus Generic Recalled

April 14, 2022

Read More »

Imcivree Approved in Treatment of Two Rare Genetic Disorders

April 14, 2022

Read More »

Avastin Biosimilar Alymsys Granted Approval

April 13, 2022

Read More »

Xigduo XR Receives New Indication for Kidney Disease

April 11, 2022

Read More »

ArmonAir Now Indicated for Younger Patient Population

April 8, 2022

Read More »

Vijoice Approved to Treat Group of Rare Genetic Disorders

April 6, 2022

Read More »

New Acute Treatment Option for Schizophrenia and Bipolar Disorder

April 6, 2022

Read More »

Benefit Advisors & Employees - Want to know more?

Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager

Full Name(Required)

Email(Required)

Comment(Required)

Company Name(Required)

CAPTCHA